Inotropic drugs in the treatment of heart failure.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000631:Aminopyridines / Q000627:therapeutic use; D000676:Amrinone; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007473:Ion Channels / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism
D000318:Adrenergic beta-Agonists; D000631:Aminopyridines; D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D007093:Imidazoles; D007473:Ion Channels; D010726:Phosphodiesterase Inhibitors; D011942:Receptors, Adrenergic, alpha; D000242:Cyclic AMP; C029758:sulmazole; D000676:Amrinone